# MiNK Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 20:08 ET
- Period: 2024-12-31
- Accession: 0000950170-25-061041
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-061041. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.